E-DRUG: Business behaviour of Boehringer Ingelheim, Bayer and Baxter in Brazil
----------------------------------------------------------------------------------
BUKO Pharma-Kampagne publishes new study
Dear e-druggers,
Please find below the link to our latest study: "At the expense of the
poor? - Examination on the business behaviour of Bayer, Baxter and
Boehringer Ingelheim in Brazil". The publication presents detailed
information on the companies´ portfolios in Brazil, access and prices of
their drugs in public and private health facilities, the companies´
marketing behaviour, patent policy and clinical studies.
The data collection in Brazil (2011-2012) was carried out by Rogério
Hoefler, a pharmacist from Centro Brasileiro de Informação sobre
Medicamentos (Cebrim) / Conselho Federal de Farmácia (CFF). The brochure
contains an annex which lists every examined drug with its price and
classification.
http://www.bukopharma.de/uploads/file/Pharma-Brief/E2012_03_special_Braz
il_final.pdf [PDF/2mB]
[Please fix URL in browser if broken]
In 2011 BUKO Pharma-Kampagne already published a study on the business
behaviour of Bayer, Baxter and Boehringer Ingelheim in India, using the
same methodology. Learn more:
http://www.en.bukopharma.de/index.php?page=Publications
[Please fix URL in browser if broken]
Please follow us on Twitter www.twitter.com/BUKOPharma
or on Facebook
https://www.facebook.com/pages/BUKO-Pharma-Kampagne/195866943847728
Hedwig Diekwisch
BUKO Pharma-Kampagne / Gesundheit und Dritte Welt e.V.
August-Bebel-Str. 62
33602 Bielefeld
Tel.: +49 (0)521 60550
Fax.: +49 (0)521 63789